SoniVie
FDA Breakthrough for the Therapeutic Intra-Vascular Ultrasound (TIVUS) System in Patients with PAH.
PAH is classified as a life-threatening or irreversibly debilitating disease because it is characterized by a pErogressive increase in pulmonary vascular resistance that leads to right-sided heart failure and death.
